SpaceX Stock Is Down 48% From Its High. Here's Why ETFs Are Loading Up Anyway.
Nasdaq News: Markets
ServiceNow's Revenue Growth Is Accelerating: Is the Stock a Buy Now?
Fool.com Headlines
AbelZeta Receives FDA Clearance of Registrational Phase II Trial for C-CAR168 in Refractory Lupus Nephritis
PR Newswire
AssureCare and CURIS Partner to Ensure RHT Funding Builds Infrastructure That Outlasts the Program
PR Newswire
Spero Therapeutics Names Debra Jeske Zack As Chief Medical Officer
Nasdaq News: Markets
Astrazeneca Q2 Earnings Call Highlights
MarketBeat
Astrazeneca Q2 Earnings Call Highlights
Nasdaq News: Earnings



